Your session is about to expire
← Back to Search
Cannabis Abstinence for Improved Cognition and Mental Health
Study Summary
This trial will test if abstaining from cannabis for 42 days can improve cognition and mental health symptoms in identical twins. One twin will abstain and the other won't, to measure the difference.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
Is eligibility for this trial restricted to certain demographics, such as people aged over sixty?
"As per the specified requirements for participation, eligible enrollees must fall between 31 and 47 years old."
Has the enrollment window for this trial closed?
"According to the clinicaltrials.gov records, this medical study is not presently accepting participants; however, it was first posted on April 24th 2023 and last modified May 8th 2023. Fortunately for those seeking treatment options, there are currently 554 other trials actively recruiting patients."
Under what criteria can participants be eligible to join this research?
"To be considered for this trial, patients must have used cannabis and fall between the ages of 31 to 47. This study is aiming to recruit a total of 100 participants."
Share this study with friends
Copy Link
Messenger